Skip to main content
Assets
iShares Russell 2000 ETF logo
IWM.NYSEARCA
iShares Russell 2000 ETF
Indices & Funds · Market Benchmark

Small-cap ETF tracking the Russell 2000 Index, providing exposure to approximately 2,000 small-cap U.S. companies across diverse industries.

HQ: United StatesListed: United States

Historical AI Consensus

Audit every published iPulse AI forecast batch and immutable historical research document for iShares Russell 2000 ETF.

Historical AI Consensus

This page preserves the research and market snapshot packaged for this batch. It is not updated with later prices or revised advisor outputs.

Symbol
IWM.NYSEARCA
Batch
7
Published
September 20, 2026
AI Advisors
14

Historical AI Consensus Investment Thesis

iShares Russell 2000 ETF (IWM) Forecast and AI Rating

Deep analysis published Original pricing snapshot 12 min read
Published 1-Year and 5-Year Forecast Outlook

Forecast targets and rating

Published batch rating

NEUTRAL

Calculated from the frozen synthesized path using the same return, horizon, volatility and dividend rules as individual opinions.

2027

1-Year

SELL ALL

$265

-6.7%-5.8% incl. dividends
2031

5-Year

NEUTRAL

$372

+30.8%+36.8% incl. dividends

Published batch insight

Refinancing Cliff Collides With Domestic Onshoring Driving Bifurcated Small Cap Horizon

Consensus reflects sharp divergence between acute near-term balance-sheet refinancing stress and durable five-year domestic onshoring expansion. Restrictive monetary policy penalizes the large unprofitable constituent cohort through elevated debt-service costs, but eventual policy easing and mechanical index purging enable high-quality survivors to drive disciplined mid-single-digit annualized price appreciation.

Deep Forecast Analysis by iPulse AI Engine

This analysis preserves the original published batch. Audit published forecasts in full transparency

Elon Musk (Visionary) advisor portraitRay Dalio (Strategist) advisor portraitMachiavelli (Insider) advisor portraitSuperintelligence (Anthropologist) advisor portraitUniversal Investor (Polymath) advisor portraitSherlock Holmes (Whistleblower) advisor portraitWarren Buffett (Value Purist) advisor portraitJ.P. Morgan (Titan) advisor portraitMichael Burry (Vulture) advisor portrait

Elon Musk (Visionary), Ray Dalio (Strategist), Machiavelli (Insider), Superintelligence (Anthropologist), Universal Investor (Polymath), Sherlock Holmes (Whistleblower), Warren Buffett (Value Purist), J.P. Morgan (Titan), Michael Burry (Vulture). Some archetypes run in multiple modes, resulting in 14 advisors total.

Computed on these frontier AI models
Gemini AI model logoGeminiClaude AI model logoClaudeChatGPT AI model logoChatGPT

Full published thesis

Executive Summary

If you invested $10,000 in iShares Russell 2000 ETF at publication: $13,683 in five years versus $13,892 for S&P 500 benchmark.

Five-year synthesized consensus forecast for iShares Russell 2000 ETFThe diagram shows the synthesized consensus value path for iShares Russell 2000 ETF, forecast milestones, and a comparison with S&P 500 benchmark. including estimated net dividends of 0.9% per year.$10,000$12,500$15,000$13,683 (+36.8%)$13,892 (+38.9%)Published2027(1Y)2028(2Y)2029(3Y)2030(4Y)2031(5Y)
iShares Russell 2000 ETF · Synthesized ConsensusS&P 500 benchmark

* Return is calculated incl. 0.9% net dividend yield for iShares Russell 2000 ETF.

Figure: Five-year synthesized consensus value path for iShares Russell 2000 ETF compared with S&P 500 benchmark. The path uses the synthesizer’s normalized opinion weights.
20-quarter synthesized forecastPrice targets, quarterly returns and the reasoning behind each step

Frozen forecast from 18 Sept 2026. Prices in USD; returns exclude dividends. Each quarter is compounded from the previous quarter.

Anchor: 284.1 USD1-year price return: -6.65%5-year price return: +30.83%

Swipe the table horizontally to read every column.

Twenty quarterly synthesized price forecasts in USD, with returns and rationale
Quarter / dateTarget (USD)Quarter returnTotal returnForecast rationale
Q118 Dec 2026274.44-3.40%-3.40%Elevated policy rates and benchmark Treasury yields near five percent compress interest coverage ratios across floating-rate debtors. Earnings revisions turn defensive, prompting institutional portfolio managers to de-risk into large-cap balance sheets.
Q218 Mar 2027264.42-3.65%-6.93%Corporate debt refinancing anxieties mount as quarterly reporting reveals margin degradation across unprofitable constituents. Persistent energy overhead and intermediate input tariffs further squeeze gross profit margins across regional consumer and industrial operators.
Q318 Jun 2027262.55-0.71%-7.59%Commercial real estate loan maturities tighten regional bank lending standards, dampening working capital availability. Illiquid constituents experience valuation de-rating, though industrial order backlogs from domestic onshoring begin establishing a cyclical floor.
Q418 Sept 2027265.20+1.01%-6.65%Stabilizing energy benchmarks and plateauing policy yields alleviate extreme downside anxiety. Opportunistic value accumulation emerges across cash-flow-generative manufacturing and logistics constituents, initiating a tentative, disciplined price recovery.
Q518 Dec 2027270.66+2.06%-4.73%Headline disinflation supports expectations of impending central bank easing. High-yield credit spreads compress from cyclical peaks, prompting institutional portfolio rebalancing toward deeply discounted small-cap value holdings into calendar year-end.
Q618 Mar 2028277.40+2.49%-2.36%An initial twenty-five-basis-point policy rate reduction delivers immediate debt-servicing relief to floating-rate corporate borrowers. Loosening credit conditions stabilize regional depository institutions, sparking a broad-based valuation relief rally across domestic cyclicals.
Q718 Jun 2028286.69+3.35%+0.91%Federal supply chain incentives and onshoring mandates translate into tangible factory equipment orders. The index reconstitution begins filtering out non-viable balance sheets, lifting aggregate return on capital and supporting multiple expansion.
Q818 Sept 2028292.57+2.05%+2.98%Corporate consolidation accelerates as private equity sponsors deploy cash reserves into undervalued small-cap targets at significant buyout premiums. Takeover liquidity establishes a firm valuation floor across beaten-down healthcare and industrial components.
Q918 Dec 2028300.50+2.71%+5.77%Subsequent rate cuts reduce borrowing costs further, stimulating capital expenditure among solvent mid-tier suppliers. Small-cap technology and commercial service providers report improving operating leverage as enterprise software automation compresses administrative overhead.
Q1018 Mar 2029307.68+2.39%+8.30%Lower debt service burdens and steady domestic consumer demand drive an orderly improvement in first-quarter corporate earnings. Multiple expansion moderates as investors require tangible operational delivery, maintaining steady, sustainable price appreciation.
Q1118 Jun 2029316.11+2.74%+11.27%Domestic infrastructure modernization projects reach active procurement phases, driving double-digit revenue expansion for small-cap engineering contractors. Favorable loan spreads reinforce regional bank net interest margins, sustaining index performance momentum.
Q1218 Sept 2029320.98+1.54%+12.98%Mid-cycle macroeconomic stabilization keeps price discovery orderly. Lingering wage pressures and tariff adjustments prevent runaway multiple expansion, leading to modest consolidation while cash-generative constituents continue steadily compounding operational cash flows.
Q1318 Dec 2029329.23+2.57%+15.88%Institutional allocators rotate capital from richly valued mega-caps into small-cap blend strategies. Solid holiday domestic retail sales and stable financing costs underpin steady year-end equity appreciation across consumer discretionary holdings.
Q1418 Mar 2030334.23+1.52%+17.65%Neutral monetary settings and low yield volatility provide an optimal operational backdrop. Surviving constituents conclude balance-sheet deleveraging, translating organic operating income gains directly into higher net cash earnings per share.
Q1518 Jun 2030341.75+2.25%+20.29%Index rebalancing reflects a markedly healthier constituent profile with a reduced share of non-earning firms. Small-cap healthcare and industrial technology innovators attract systematic smart-beta inflows, propelling steady fund price discovery.
Q1618 Sept 2030346.95+1.52%+22.12%Domestic manufacturing hubs achieve sustained commercial throughput, supporting resilient supplier revenues. A brief late-summer pause in factory equipment orders limits quarterly advance, keeping overall index gains modest but fundamentally sound.
Q1718 Dec 2030354.27+2.11%+24.70%Year-end earnings execution confirms durable operating margin expansion resulting from multi-year operational automation. Broad sector participation across regional banking, specialty chemicals, and business services lifts the fund into year-end.
Q1818 Mar 2031359.58+1.50%+26.57%Late-cycle macroeconomic conditions maintain non-inflationary domestic growth. Benign corporate default rates and manageable refinancing schedules allow small-cap equities to preserve valuation gains, generating incremental price appreciation across the portfolio.
Q1918 Jun 2031365.95+1.77%+28.81%Matured domestic supply-chain networks and robust corporate share repurchases provide strong equity price support. High-quality surviving champions capture consolidated market share, maintaining solid constituent profitability despite moderate economic deceleration.
Q2018 Sept 2031371.69+1.57%+30.83%The five-year forecast horizon concludes in mature equilibrium, having absorbed the 2026-2027 debt-refinancing cycle. Disciplined constituent capital structures and normalized operating earnings establish sustainable multi-year valuation benchmarks.

The base-case economic thesis resolves into an asymmetric, two-phase structural progression. In the initial eighteen months, restrictive monetary policy and five percent benchmark yields penalize a basket where forty percent of constituents generate negative net income and thirty-eight percent of liabilities carry floating interest rates. Refinancing an estimated seven-hundred-billion-dollar corporate maturity wall compresses aggregate pre-tax earnings and forces valuation multiples lower. However, as terminal disinflation enables central-bank easing toward neutral from 2028 onward, surviving domestic producers capitalize on aggressive federal supply-chain reshoring procurement and agentic operational automation. Valuation sensitivity remains tightly coupled to long-term discount rates; a failure of term premia to normalize represents the premier counterargument.

Key insights

  • Unscreened benchmark construction exposes investors to chronic dilution from unprofitable constituents, making mechanical index reconstitution the primary driver of fundamental ROE repair.
  • Floating-rate debt concentration creates extreme operational leverage to central-bank rate trajectories, producing severe near-term margin compression followed by outsized recovery beta.
  • Domestic revenue insulation shelters small caps from foreign retaliatory trade actions, yet leaves operating margins vulnerable to intermediate input cost inflation.

Deep Dive

Prevailing market consensus champions a small-cap catch-up rally, asserting that historic valuation discounts relative to large-cap technology benchmarks guarantee explosive outperformance once monetary policy eases. Sell-side research relies on aggregate price-to-sales ratios, assuming small businesses can smoothly absorb current interest rates and roll over maturing obligations without experiencing severe equity dilution or margin degradation.